Renin-angiotensin system and cardiovascular risk.

By R. Schmieder, K. Hilgers, M. Schlaich, B. Schmidt. The Lancet, 2007

648 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism

View Paper: https://www.semanticscholar.org/paper/d9fdd368233494b34c06faad84febae370f66c08

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. S. Laurent
2. E. Schiffrin
3. H. S. Boudier
4. Giuseppe Remuzzi
5. B. K. Pedersen
6. B. Saltin

Citations in the corpus

• The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. (2013, background): “Several RCTs have clearly indicated that RAS blockade is more effective in reducing albuminuria than either placebo or other antihypertensive agents in diabetic nephropathy, non-diabetic nephropathy and patients with CVD [513,537], and is also effective in preventing incident microalbuminuria [329,5”
• 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. (2018, neutral): “, 2007 (254) 17416265 Study type: Topic review Inclusion criteria: N/A”
• Angiotensin II revisited: new roles in inflammation, immunology and aging (2010, background): “Neuroprotective action of ARB against ischemic injury has also been shown to prevent stroke in experimental and clinical studies (Schmieder et al, 2007; Turnbull, 2003).”
• BATMAN-TCM: a Bioinformatics Analysis Tool for Molecular mechANism of Traditional Chinese Medicine (2016, background): “…and further lower myocardial contractility 31 ; 3) Aminoacyl-tRNA biosynthesis (adjusted P-value = 3.06e-12) is associated with cardiac angiogenesis 32 ; 4) Activated renin-angiotensin system (RAAS) (adjusted P-value = 4.70e-02) is closely related with cardiovascular function deterioration 33 .”
• 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) (2007, background): “Several RCTs have clearly indicated that RAS blockade is more effective in reducing albuminuria than either placebo or other antihypertensive agents in diabetic nephropathy, non-diabetic nephropathy and patients with CVD [513,537], and is also effective in preventing incident microalbuminuria [329,5”